[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100541439":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":25,"locations":30,"responsibleParty":53,"collaborators":25,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":25,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":25,"studyType":70,"phases":71,"briefSummary":74,"conditions":75,"keywords":25,"overallStatus":33,"whyStopped":25,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"control group","ACTIVE_COMPARATOR","patients were on sitagliptin 100mg \u002Fday monotherapy",[13],"Drug: Sitagliptin 100mg",{"label":15,"type":10,"description":16,"interventionNames":17},"Comparative group","patients were on sitagliptin 100mg \u002Fday monotherapy plus doxycycline 100 mg",[13,18],"Drug: Doxycyclin",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Sitagliptin 100mg","Sitagliptin is used along with diet and exercise and sometimes with other medications to lower blood sugar levels in adults with type 2 diabetes",[15,9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Doxycyclin","Doxycycline belongs to the class of medicines known as tetracycline antibiotics. It works by killing bacteria or preventing their growth.",[15],[31],{"facility":32,"status":33,"city":34,"state":25,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Tanta Unuversity","RECRUITING","Tanta","31527","Egypt","EG",{"type":39,"coordinates":40},"Point",[41,42],31.00192,30.78847,{"lat":42,"lon":41},[45,50],{"name":46,"role":47,"phone":48,"phoneExt":25,"email":49},"Eman I Elberri, PhD","CONTACT","0201003592593","mbahaa@horus.edu.eg",{"name":51,"role":52,"phone":25,"phoneExt":25,"email":25},"Mostafa M Bahaa, PhD","SUB_INVESTIGATOR",{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"SPONSOR_INVESTIGATOR","Mostafa Bahaa","Teaching assisstant","100541439","phase-1-doxycycline-in-type-ii-diabetes-100541439",false,"NCT06329882","Doxycycline in Type II Diabetes","Doxycycline in Combination With Sitagliptin on the Glycemic and Cardiac Indices in Patients With Type 2 Diabetes Mellitus","Inclusion Criteria:\n\n* Male or female sex more than 40 years old Newly diagnosed type II diabetes. HbA1c more than 6.5\n\nExclusion Criteria:\n\n* Patient with chronic kidney disease, hepatic disorders, mental and psychiatric disorders, pregnancy, and lactation","ALL","40 Years","60 Years",{"count":68,"type":69},60,"ESTIMATED","INTERVENTIONAL",[72,73],"PHASE1","PHASE2","Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia, weight loss, and cardio-metabolic complications. T2DM develops due to the progression of insulin resistance (IR), impairment of insulin insensitivity, and failure of the pancreatic β-cells to release sufficient amount of insulin in response to glucose burden",[76],"Diabetes Mellitus, Type 2","2025-04-03",{"date":79,"type":80},"2025-04-04","ACTUAL",{"date":82,"type":80},"2024-03-30",{"date":84,"type":69},"2026-04-20",{"name":55,"class":6},1]